Leading the way to safer medication
 Crosscheck  Recommender

Anagrelide

Description

Anagrelide is an inhibitor of cyclic AMP phosphodiesterase III and suppress expression of transcription factors including GATA-1 and FOG-1 required for megakaryocytopoiesis, ultimately leading to reduced platelet production.

ATC Classification

Code
Title
Category
L01XX35
Anagrelide
L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XX Other antineoplastic agents

Trade names

Trade name
Countries

Canada Singapore United States

Austria

Austria

Austria Cyprus Netherlands

Austria

Product Monographs

Monograph
Type
Country
XAGRID Capsule
MPI, EU: SmPC
AGRYLIN Capsule
MPI, US: SPL/PLR
US